secwatch.observer — SEC 8-K summary
======================================

Issuer:     Acumen Pharmaceuticals, Inc. (ABOS)
CIK:        0001576885
Form:       8-K
Filed at:   2025-06-05T23:59:59+00:00
Accession:  0001576885-25-000072
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acumen shareholders elect three Class I directors, ratify EY as auditor
-----------------------------------------------------------------------

- Elected Kimberlee C. Drapkin, Jeffrey Ives, and Sean Stalfort as Class I directors until 2028 with ~30M votes each; ~17.5M broker non-votes.
- Ratified Ernst & Young as independent auditor for FY2025: 51.4M for, 118,735 against, 35,514 abstain.
- Approximately 85% of outstanding shares (51.5M of 60.6M) were present or represented at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576885/000157688525000072/0001576885-25-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576885/000157688525000072/abos-20250604.htm
  HTML page:      https://secwatch.observer/filing/0001576885-25-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer